HPV, histologic grade and age: Risk factors for the progression of cervical intraepithelial neoplasia

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 7, 1998, Pages 561-566

  Konno, Ryo ^a   Paez, Ceser ^a   Sato, Shinji ^a   Yajima, Akira ^a   Fukao, Akira ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Age; Cervical intraepithelial neoplasia; Human; Papillomavirus; Risk factors

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER GRADING; CANCER REGRESSION; CANCER RISK; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0031815178     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Koss L: Pathogenesis of carcinoma of the uterine cervix. Curr Topics Pathol 1981;70:11-142
2. Cheetham D, Smith J, Wilson C, et al: Clinical significance of human papillomavirus infection of the uterine cervix in the development of cervical intraepithelial neoplasia. Br J Vener Dis 1983;60:182-185
3. Stern E, Neeley P: Dysplasia of the uterine cervix: Incidence of regression, recurrence, and cancer. Cancer 1964;17: 508-512
4. Yajima A, Sato A, Mori T, et al: Progression to malignancy of severe dysplasia of the uterine cervix. Tohoku J Exp Med 1982;136:433-438
5. Brinton L, Fraumeni J: Epidemiology of uterine cervical cancer. J Chronic Dis 1986;39:1051-1065
6. Carmichael J, Maskens P: Cervical dysplasia and human papillomavirus. Am J Obstet Gynecol 1989;160:916-918
7. Arends M, Donaldson Y, Duvall E, et al: HPV in full thickness cervical biopsies: High prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 1991;165: 301-309
8. Lorincz A, Reid R, Jenson A, et al: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-337
9. DiPaolo J, Popescu N, Alvarez L, et al: Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit Rev Oncog 1993;4:337-360
10. Levine A, Harper J, Hilborne L, et al: HPV DNA and the risk of squamous intraepithelial lesions of the uterine cervix in young women. Am J Clin Pathol 1993;100:6-11
11. Munoz N, Bosch X, Kaldor J: Does human papillomavirus cause cervical cancer?: The state of the epidemiological evidence. Br J Cancer 1988;57:1-5
12. Reeves W, Brinton L, Garcia M, et al: Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989;320:1437-1441
13. Paez C, Konno R, Yaegashi N, et al: Prevalence of HPV DNA in various cervical lesions from Ecuador and Japan. Tohoku J Exp Med 1996;180:261-272
14. Rogo K, Evander M, Bjersing L, et al: HPV infection in African cervical cancer detected by polymerase chain reaction. Anticancer Res 1991;11:169-174
15. Melkert PW, Hopman E, van dem Brule AJ, et al: Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-923
16. Hellberg D, Nilsson S, Grad A, et al: Behaviour of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types. Arch Gynecol Obstet 1993;252: 119-128
17. Kataja V, Syrjanen S, Mantyjarvi R, et al: Prognostic factors for cervical human papillomavirus infections. Sex Transm Dis 1992;19:154-160
18. Kurman R, Norris H, Wilkinson E: Tumors of the Cervix. Washington, DC, Armed Forces Institute of Pathology, 1992
19. Fujinaga Y, Shimada M, Okazawa K, et al: Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991;72: 1039-1044
20. Maki H, Saito S, Ibaraki T, et al: Use of universal and type-specific primers in the polymerase chain reaction for the detection and typing of genital human papillomaviruses. Jpn J Cancer Res 1991;82:411-419
21. Nuovo G, MacConnell P, Forde A, et al: Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol 1991;139:847-853
22. Ley C, Bauer H, Reingold A, et al: Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003
23. Broso P: The age for beginning and the frequency for performing the Pap test. Minerva Ginecol 1994;46:565-569
24. Kataja V, Syrjanen K, Syrjanen S, et al: Prospective follow-up of genital HPV infections: Life-table analysis of HPV typing data. Eur J Epidemiol 1989;5:1-7
25. Syrjanen K, Hakama M, Saarikoski S, et al: Prevalence, incidence and estimated life time risk of cervical human papillomavirus infection in a non selected Finnish female population. Sex Transm Dis 1990;17:15-19
26. Konno R, Sato S, Yajima A: Progression of squamous cell carcinoma of the uterine cervix from cervical intraepithelial neoplasia infected with human papillomavirus: A retrospective follow-up study by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1992;11:105-112
27. Ho G, Burk R, Klein S, et al: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-1371
28. Kutteh W, Hatch K, Blackwell R, et al: Secretory immune system of the female reproductive tract: I. Immunologlobulin and secretory component-containing cells. Obstet Gynecol 1988;71:56-60
29. Chen LP, Thomas EK, Hu SL, et al: Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci 1991;88:110-114
30. Tigges M, Koelle D, Hartog K, et al: Human CD8+ herpes simplex virus-specific cytotoxic T lymphocyte clones recognize diverse virion protein antigens. J Virol 1992;66: 1622-1633
31. Cromme F, Meijer C, Snijders P, et al: Analysis of MHC class I and class II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 1993;67:1372-1380
32. Garzetti G, Ciavattini A, Goteri G, et al: HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: Integration between virus and immune system. Gynecol Obstet Invest 1995;39:130-135
33. Odunsi K, Terry G, Ho L, et al: Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia. Mol Med 1995;1:161-171